Vardenafil: all 61 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaRecruitingNCT06491108Phase 3
- Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving MaravirocCompletedNCT00853840Phase 4Results posted
- Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic SyndromeCompletedNCT00738400Phase 4Results posted
- A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder FunctionCompletedNCT00478881Phase 2Results posted
- Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate HypertrophyCompletedNCT00461123Phase 2Results posted
- Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the NewbornCompletedNCT06860399Phase 1/2
- Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver CirrhosisStatus unknownNCT02344823Phase 4
- Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesTerminatedNCT02279992Early Phase 1
- Diabetes & VardenafilCompletedNCT02219646Phase 2
- Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled IloprostStatus unknownNCT01649739Phase 4
- Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's SyndromeCompletedNCT01291199Phase 2/3
- The Safety of Vardenafil in Patients Undergoing Cardiac SurgeryCompletedNCT01260285Phase 1
- Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 InhibitorsCompletedNCT01168817Phase 2
- Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552CompletedNCT01110590Phase 1
- Correlation Study of Vascular Parameters in Hypertensive Men With Erectile DysfunctionCompletedNCT01084187Phase 4
- Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?TerminatedNCT01002534Phase 2
- Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile DysfunctionCompletedNCT00786253Phase 2
- A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord InjuryStatus unknownNCT00725790Phase 4
- The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00718952Phase 3
- Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.Status unknownNCT00705588Phase 4
- Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 WeeksCompletedNCT00682019Phase 3
- Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00681772Phase 4
- BAY38-9456 - Pivotal Trial for Diabetes PatientCompletedNCT00678704Phase 3
- Assessment of Vardenafil in Patients With Erectile Dysfunction in AsiaCompletedNCT00668135Phase 4
- Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaCompletedNCT00668109Phase 3
- A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.CompletedNCT00668096Phase 4
- BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.CompletedNCT00668057Phase 3
- Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 HoursCompletedNCT00668018Phase 3
- Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and HypertensionCompletedNCT00668005Phase 3
- Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to IntercourseCompletedNCT00667979Phase 4
- Assess Efficacy in Subjects With Traumatic Spinal Cord InjuryCompletedNCT00667966Phase 4
- Vardenafil in TinnitusCompletedNCT00666809Phase 2
- A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile DysfunctionCompletedNCT00665496Phase 3
- Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)CompletedNCT00665340Phase 4
- BAY38-9456, 5/10/20mg, vs.Placebo in Erectile DysfunctionCompletedNCT00665054Phase 4
- Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and HyperlipidemiaCompletedNCT00663845Phase 4
- Assessment of Duration of Erection With Vardenafil 10 mgCompletedNCT00663728Phase 4
- Levitra® - Real Life Safety and Efficacy of LevitraCompletedNCT00663598Phase 4
- Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)CompletedNCT00663130Phase 4
- Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00662441Phase 4
- A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile DysfunctionCompletedNCT00661700Phase 3
- Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile DysfunctionCompletedNCT00661596Phase 3
- Study Evaluating the Efficacy, Safety, and Reliability of VardenafilCompletedNCT00661297Phase 3
- Depression Related Improvement With Vardenafil for Erectile ResponseCompletedNCT00661219Phase 3
- To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.CompletedNCT00661115Phase 3
- Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 DiabetesCompletedNCT00660998Phase 4
- Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00658177Phase 3
- Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic HyperplasiaCompletedNCT00657839Phase 2
- Efficacy and Safety of Vardenafil in Men With Erectile DysfunctionCompletedNCT00657644Phase 3
- Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile DysfunctionCompletedNCT00657033Phase 3
- Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00656188Phase 2/3
- Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm FunctionCompletedNCT00655590Phase 4
- A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile DysfunctionCompletedNCT00654914Phase 3
- Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord InjuryCompletedNCT00654680Phase 3
- BAY38-9456 - Supportive Trial for Spinal InjuryCompletedNCT00652262Phase 3
- Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITSCompletedNCT00517179Not applicable
- Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5iStatus unknownNCT00498680Phase 4
- Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving EDCompletedNCT00492635Phase 3
- FDA Phase IV - Commitment - Retinal Function StudyCompletedNCT00461565Phase 4
- A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and DyslipidemiaCompletedNCT00379756Phase 4
- Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study IICompletedNCT00377793Phase 4